📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-21 15:14
298 analysed today
FollowTelegram
298
Today
149,699
All-time analysed
42,924
Positive
6,662
Negative
91,432
Neutral
8,613
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
One Global Revises Preferential Issue Price to ₹560.13 and ₹558.99 on BSE Directive for M&A
One Global Service Provider Limited has issued a corrigendum to its 34th AGM notice regarding a preferential equity issue for acquiring stakes in Matrix Labs Diagnocare and Matrix Labs Private Limited. Following BSE observations, the issue price was revised upwards from ₹553 per share to ₹560.13 for MLDPL and ₹558.99 for MLPL. The total non-cash consideration remains unchanged at ₹39.54 Cr (₹35.98 Cr for MLDPL and ₹3.56 Cr for MLPL), resulting in a slight reduction in allotted shares to 7,06,068 shares. Post-allotment, promoter holding will dilute from 68.40% to 66.01%.
Confidence: HIGH
What changedUpward revision in preferential issue price from ₹553 to ₹560.13/₹558.99 following BSE observations, slightly reducing total shares issued while keeping deal consideration constant.
Why it mattersEnsures regulatory compliance under SEBI ICDR pricing norms for acquiring stakes in the two Matrix Labs entities, resulting in marginally less equity dilution for existing shareholders.
Total deal consideration: Rs. 39,54,17,120Deal value vs TTM revenue: ~7.7%Revised MLDPL price per share: Rs. 560.13Revised MLPL price per share: Rs. 558.99Total equity shares to be allotted: 7,06,068Post-issue promoter holding: 66.01%
📅 Short termProcedural resolution update; ensures AGM voting proceeds smoothly without exchange hurdles.
📈 Long termSupports inorganic growth in the diagnostics and healthcare service vertical through Matrix Labs integration, with minimal incremental dilution.
⚠ Risk flags
- Equity dilution of existing public and promoter shareholders by ~3.6%
- Integration and execution risks associated with the acquired Matrix Labs entities
Key Highlights
Preferential issue price revised upwards from ₹553.00 to ₹560.13 per share for MLDPL and ₹558.99 for MLPL based on BSE advice.
Total consideration stays unchanged at ₹35,97,81,800 for MLDPL and ₹3,56,35,320 for MLPL (combined ~₹39.54 Cr).
Total shares to be issued reduced slightly to 7,06,068 equity shares for acquisition consideration other than cash.
Promoter shareholding post-issue reduces from 68.40% to 66.01%, diluting by 239 bps.
E-voting for the 34th AGM is scheduled from September 25 to September 28, 2026, ahead of the AGM on September 29, 2026.
👀 What to Watch
Track shareholder voting results at the AGM on September 29, 2026, and final regulatory in-principle/listing approvals from BSE for the preferential allotment.
Appoints CA Niraj Chordia as CFO; Q1 Net Profit Up 45.6% YoY to ₹14.30 Cr
One Global Service Provider has appointed CA Niraj Chordia as Chief Financial Officer and Key Managerial Personnel effective August 14, 2026, bringing over 18 years of finance and compliance experience. In the same meeting, internal auditor M/s Rushil Soni & Co. resigned due to professional preoccupations. Additionally, the company approved its Q1 FY27 results, reporting standalone revenue of ₹102.77 Cr (up 17.0% YoY) and net profit of ₹14.30 Cr (up 45.6% YoY from ₹9.82 Cr).
Confidence: HIGH
What changedCA Niraj Chordia took charge as CFO/KMP, the internal auditor resigned, and Q1 FY27 standalone financial results were declared.
Why it mattersAdds experienced leadership to the senior finance function to support governance while affirming steady YoY earnings momentum.
Q1 FY27 Revenue: ₹10,277.32 LacsQ1 FY27 Net Profit: ₹1,429.61 LacsYoY Net Profit Growth: 45.59%Effective Appointment Date: 14/08/2026
📅 Short termStable to positive sentiment given robust YoY earnings expansion, though revenue saw a sequential decline from Q4 FY26.
📈 Long termExperienced financial leadership strengthens corporate governance as the company scales its dual healthcare and IT service segments.
⚠ Risk flags
- Resignation of internal auditor
- Sequential QoQ revenue decline of 23.2%
Key Highlights
Appointed CA Niraj Chordia as Chief Financial Officer and Key Managerial Personnel w.e.f. August 14, 2026.
Reported Q1 FY27 standalone revenue from operations of ₹10,277.32 Lacs (₹102.77 Cr), up 17.0% YoY.
Q1 FY27 net profit grew 45.6% YoY to ₹1,429.61 Lacs (₹14.30 Cr) with basic EPS of ₹7.32.
Resignation of internal auditor M/s Rushil Soni & Co. accepted w.e.f. August 14, 2026 due to other professional commitments.
👀 What to Watch
Monitor the appointment of the incoming internal auditor and track whether Q1's strong YoY profitability margins can be sustained across upcoming quarters.
One Global Q1 PAT Rises 45.6% YoY to Rs 14.30 Cr; Appoints Niraj Chordia as CFO
One Global Service Provider reported a 17.0% YoY increase in standalone revenue from operations to Rs 102.77 Cr for Q1 FY27 compared to Rs 87.83 Cr in Q1 FY26, though revenue declined 23.2% sequentially from Rs 133.81 Cr in Q4 FY26. Standalone profit after tax (PAT) grew 45.6% YoY to Rs 14.30 Cr (vs. Rs 9.82 Cr in Q1 FY26), yielding an EPS of Rs 7.32. Operating margins held steady as purchase of stock in trade was Rs 80.17 Cr. Alongside results, the Board appointed CA Niraj Chordia as Chief Financial Officer and accepted the resignation of internal auditor Rushil Soni & Co.
Confidence: HIGH
What changedReported Q1 FY27 standalone financial results with YoY profit expansion, appointed a new Chief Financial Officer, and noted the resignation of internal auditors.
Why it mattersDemonstrates sustained annual earnings growth in core operations, while key management changes (new CFO) aim to reinforce corporate financial governance.
Revenue from Operations (Q1 FY27): Rs 10,277.32 LakhsNet Profit / PAT (Q1 FY27): Rs 1,429.61 LakhsBasic EPS: Rs 7.32YoY PAT Growth: 45.59%QoQ Revenue Growth: -23.19%
📅 Short termThe market is likely to react positively to the strong 45.6% YoY bottom-line growth, balanced against the QoQ moderation from Q4.
📈 Long termGrowth sustainability will depend on scaling high-margin healthcare diagnostics and IT service offerings while navigating regulatory pricing controls.
⚠ Risk flags
- Resignation of internal auditors
- Sequential (QoQ) revenue decline of 23.2%
Key Highlights
Standalone revenue from operations increased 17.0% YoY to Rs 10,277.32 Lakhs (Rs 102.77 Cr) in Q1 FY27
Net profit (PAT) grew 45.6% YoY to Rs 1,429.61 Lakhs (Rs 14.30 Cr) vs Rs 981.90 Lakhs in Q1 FY26
Basic and diluted EPS stood at Rs 7.32 for the quarter against Rs 5.02 in Q1 FY26
Board approved the appointment of CA Niraj Chordia as Chief Financial Officer (CFO) w.e.f. August 14, 2026
Internal Auditor M/s Rushil Soni & Co. resigned citing professional preoccupations
👀 What to Watch
Track sequential revenue stability over the upcoming quarters following the seasonal drop from Q4 FY26, alongside execution updates on healthcare and IT service integrations.
Q1 PAT up 45.6% YoY to ₹14.30 Cr; Revenue rises 17% to ₹102.77 Cr; New CFO Appointed
One Global Service Provider reported a 17.0% YoY increase in standalone revenue from operations to ₹102.77 Cr for Q1 FY27 (quarter ended June 30, 2026) compared to ₹87.83 Cr in Q1 FY26. Net profit rose 45.6% YoY to ₹14.30 Cr from ₹9.82 Cr, translating to a basic EPS of ₹7.32 (vs ₹5.02 in Q1 FY26). On a sequential basis, revenue and net profit declined by 23.2% and 21.4% respectively compared to Q4 FY26 (Revenue: ₹133.81 Cr, PAT: ₹18.19 Cr). Additionally, the Board appointed CA Niraj Chordia as Chief Financial Officer (CFO) and noted the resignation of internal auditor M/s Rushil Soni & Co.
Confidence: HIGH
What changedApproved Q1 FY27 standalone unaudited financial results and appointed CA Niraj Chordia as Chief Financial Officer.
Why it mattersDemonstrates robust YoY earnings expansion with PAT rising 45.6%, though sequential operational softening warrants monitoring.
Revenue from Operations (Q1 FY27): ₹10,277.32 LacsNet Profit (Q1 FY27): ₹1,429.61 LacsYoY Net Profit Growth: 45.6%Basic EPS: ₹7.32
📅 Short termStrong YoY earnings growth should provide support, though the sequential revenue decline from Q4 FY26 levels may temper immediate market enthusiasm.
📈 Long termSustained high profitability and low leverage provide financial resilience; long-term trajectory depends on expanding tech-driven diagnostic services and scaling high-margin IT solutions.
⚠ Risk flags
- Sequential contraction in revenue (-23.2% QoQ) and PAT (-21.4% QoQ)
- Resignation of internal auditor citing professional preoccupations
Key Highlights
Revenue from operations grew 17.0% YoY to ₹10,277.32 Lacs in Q1 FY27 compared to ₹8,782.62 Lacs in Q1 FY26.
Standalone Net Profit increased 45.6% YoY to ₹1,429.61 Lacs from ₹981.90 Lacs in the prior-year period.
Basic EPS expanded to ₹7.32 for the quarter from ₹5.02 in Q1 FY26 (and ₹9.31 in Q4 FY26).
Appointed CA Niraj Chordia as CFO and Key Managerial Personnel effective August 14, 2026.
👀 What to Watch
Track whether revenue momentum recovers from the sequential dip (down 23.2% QoQ) in upcoming quarters and watch for the appointment of a new internal auditor.
